HomePage

Flamel Technologies is a specialty pharmaceutical company with a long history of expertise in drug delivery, focusing on the development of safer and more efficacious formulations, tackling unmet medical needs in the process.

Technology Platforms

  • Medusa®

    Controlled release of injected biologics and small molecules drugs.

    Read more

  • LiquiTime®

    Controlled release oral liquid drugs.

    Read more

  • Micropump®

    Controlled release of oral drugs.

    Read more

  • Trigger Lock™

    Tamper-resistant controlled release formulations of narcotics and other drugs prone to abuse.

    Read more

  • DeliVax®

    Enhanced formulation of vaccines.

    Read more

Partnering

Flamel Technologies has an active licensing program and is proactively seeking partners with either small or large molecules for its drug delivery technologies.

Read more

Investors

As a publicly-held company, Flamel Technologies strives to use its technologies to create extraordinary shareholder value.

Read more